Conference Reports for NATAP

(APASL) 24th Conference of the Asian Pacific Association for the Study of the Liver 12-15 March, 2014 Brisbane, Australia Back

Once Daily Sofosbuvir/Ledipasvir Fixed-Dose Combination With Ribavirin in Patients With Inherited Bleeding Disorders and HCV Infection       Reported by Jules Levin Asian Pacific Association for the Study of the Liver (APASL), March 12-15, 2014, Brisbane, Australia   Catherine A. Stedman,1 Robert H. Hyland,2 Xiao Ding,2 Phil S. Pang,2 William T. Symonds,2 John G. McHutchison,2 Edward J. Gane3 1Christchurch Clinical Studies Trust, Christchurch, New Zealand; 2Gilead Sciences, Inc, Foster City, CA, USA; 3Auckland Clinical Studies, Auckland, New Zealand